PharmaSutra: Mark your calendar

Mark your calendars for PharmaSutra — featuring animations by MaRS tenant, AXS Studio — which airs this Saturday, December 6th at 7PM on CTV.

This one hour HD special documents the race to discover and market “Female Viagra” — a huge new market segment for the pharmaceutical industry.

In 1999, the Journal of the American Medical Association published a report claiming that 43% of women suffer from Female Sexual Dysfunction (FSD). Despite the critics, the so-called disease has been identified, opening up a whole new avenue of research and new potential for the “it” drug of the decade.

In this show, meet the experts behind current research and, through CGI, explore the latest theories of the neurobiology of female desire.

For more info, check out the CTV website.

Related Blogs

 

MaRS tenant draws kudos for migraine drug
Windhover Information Inc. — one of the world’s leaders in health-care strategy, industry trends and medical start-up analysis — has selected a migraine compound in development by a

Entrepreneurs in Action
At MaRS, we work with hundreds of early-stage companies to help them grow their businesses. Sometimes, some of those companies do great things: they win awards, secure financing, enter into partnershi

Receptor Therapeutics raises $500,000
Receptor Therapeutics Inc. – a MaRS tenant – has raised $500,000 from the OICR’s IPDC Program via its OncoTek Drug Delivery Inc. subsidiary. The funds will be used to drive the pre

Better protein-based therapeutics in the making
You don’t need to read a blog to know that drug development is a tough business to be in these days, especially with high failure rates in clinical trials and extended times for regulatory approval.

Developing a pharmaceutical product? Gain key tips to optimize your development process!
Moving from drug discovery to drug development requires a particular skillset usually not yet honed by start-ups. Colin Minchom, President Cordack Inc., shared his views on the Chemistry, Manufacturin

Ontario start-ups find success at BioPartnering Europe 2011
Innovative Ontario start-ups extended their global reach last month, generating some promising leads for financing and licensing deals at the 2011 BioPartnering Europe conference. The good news made t

Tags: axs, drug development, pharma, tenants